Literature DB >> 11165413

Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations.

A Potti1, M Abdel-Raheem, R Levitt, D A Schell, S A Mehdi.   

Abstract

Intramedullary spinal cord metastasis (ISCM) is an unusual occurrence in systemic cancer, occurring in as few as 2% of autopsy cases and also represents 8.5% of all cases of central nervous system metastases. Although ISCM from small cell lung carcinoma is well documented, ISCM from non-small cell lung carcinoma of the lung is rarely diagnosed prior to the patients' demise and very little data regarding outcomes exists in such patients. We present the results of our observational case series to better delineate the presentation and clinical course of this uncommon entity which shows that ISCM may present atypically and should be considered in any patient with a previous history of bronchogenic carcinoma and neurologic symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11165413     DOI: 10.1016/s0169-5002(00)00177-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  18 in total

Review 1.  Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature.

Authors:  Christos Kosmas; Maria Koumpou; Maria Nikolaou; John Katselis; Georgia Soukouli; Nina Markoutsaki; Vassiliki Kostopoulou; Assimina Gaglia; Nikolaos Mylonakis; Athanassios Karabelis; Dimitrios Pectasides
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung Adenocarcinoma.

Authors:  Keita Masuzawa; Takanori Asakura; Shinnosuke Ikemura; Hiroyuki Yasuda; Ichiro Kawada; Sosuke Takaoka; Yuichiro Hayashi; Takeshi Nakajima; Masami Arai; Koichi Fukunaga; Kenzo Soejima
Journal:  JCO Precis Oncol       Date:  2020-02-14

3.  Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case report.

Authors:  Kester A Phillips; Elizabeth Gaughan; Alejandro Gru; David Schiff
Journal:  CNS Oncol       Date:  2017-10-16

4.  The normal variant (18)F FDG uptake in the lower thoracic spinal cord segments in cancer patients without CNS malignancy.

Authors:  Geetika Bhatt; Xiao-Feng Li; Angita Jain; Vivek R Sharma; Jianmin Pan; Archana Rai; Shesh Nath Rai; A Cahid Civelek
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-07-10

5.  Intramedullary spinal cord metastasis in a patient with colon cancer: a case report.

Authors:  Vassilios Vassiliou; Dimitrios Papamichael; Petros Polyviou; Alona Koukouma; Dimitrios Andreopoulos
Journal:  J Gastrointest Cancer       Date:  2012-06

6.  Contralateral referred pain in a patient with intramedullary spinal cord metastasis from extraskeletal small cell osteosarcoma.

Authors:  Kyusik Kang; Jeong-Hee Lee; Hoon-Gu Kim
Journal:  J Spinal Cord Med       Date:  2013-04-12       Impact factor: 1.985

7.  A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer.

Authors:  Shojiro Minomo; Akihiro Tokoro; Tomoki Utsumi; Masahiro Ishihara; Masanori Akira; Shinji Atagi
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

8.  Successful osimertinib treatment in a patient who exhibited intramedullary spinal cord metastases of lung adenocarcinoma with an acquired EGFR T790M mutation.

Authors:  Kohei Horiuchi; Takanori Asakura; Shinji Sakaguchi; Fumitake Saito
Journal:  BMJ Case Rep       Date:  2019-06-21

9.  Current insights into surgery for intramedullary spinal cord metastases: a literature review.

Authors:  Ondrej Kalita
Journal:  Int J Surg Oncol       Date:  2011-05-26

10.  Metastatic spine disease in lung cancer patients: national patterns of radiation and surgical care.

Authors:  Patrick D Kelly; Scott L Zuckerman; Khoi D Than; Albert Attia; Jerry J Jaboin
Journal:  J Spine Surg       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.